Suppr超能文献

丙型肝炎病毒核心蛋白调节干扰素诱导的Jak/Stat信号通路的反式作用因子,但不影响下游IRF-1或561基因的激活。

Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.

作者信息

Basu A, Meyer K, Ray R B, Ray R

机构信息

Department of Internal Medicine, Saint Louis University, St. Louis, Missouri 63110, USA.

出版信息

Virology. 2001 Sep 30;288(2):379-90. doi: 10.1006/viro.2001.1100.

Abstract

Hepatitis C virus (HCV) has a propensity to cause chronic infection, with a low proportion of patients exhibiting a sustained response to interferon-alpha (IFNalpha) therapy. An earlier report suggested that HCV inhibits IFNalpha-induced signal transduction through the Jak/Stat pathway by preventing the formation of the transacting factor ISGF3 complex, although the effect on downstream pathway and the specific viral protein responsible for inhibition of IFNalpha-mediated signal transduction were not elucidated. HCV core protein displays a number of intriguing functional properties and has been implicated in virus-mediated pathogenesis. In this study, we have analyzed the effect of core protein upon IFNalpha- or IFNgamma-induced regulation of the Jak/Stat signaling pathway. HCV core protein expression exhibited a reduced Stat1 expression in IFN-treated mammalian cells. A gel retardation assay suggested a reduced level of formation of the transacting factors, GAF and ISGF3, in IFN-treated cells. Further studies from protein expression and RNase protection assay revealed that the reduced level of GAF or ISGF3 formation could be attributed to modulation of Stat1 protein expression, an important player for innate immunity in host defense mechanism. However, these modulatory effects did not interfere with the activation of the downstream effector genes, IRF-1 and 561, in IFN-treated cells. Stable transfectants of cells after introduction of a plasmid DNA encoding both the structural and the nonstructural proteins of HCV also exhibited a similar effect. Taken together, these results suggest that although expression of the core protein alone or with other HCV proteins modulate transacting factors of Jak/Stat signaling pathway, expression of the downstream effector genes IRF-1 and 561 remains unaffected upon IFN treatment and may contribute to host defense mechanism.

摘要

丙型肝炎病毒(HCV)易于引发慢性感染,仅有低比例患者对α干扰素(IFNα)治疗呈现持续应答。一份较早的报告表明,HCV通过阻止反式作用因子ISGF3复合物的形成,抑制IFNα诱导的Jak/Stat信号转导途径,不过对下游途径以及负责抑制IFNα介导的信号转导的特定病毒蛋白的影响尚未阐明。HCV核心蛋白展现出诸多引人关注的功能特性,并与病毒介导的发病机制有关。在本研究中,我们分析了核心蛋白对IFNα或IFNγ诱导的Jak/Stat信号通路调节的影响。在经IFN处理的哺乳动物细胞中,HCV核心蛋白的表达使Stat1表达降低。凝胶阻滞分析表明,在经IFN处理的细胞中,反式作用因子GAF和ISGF3的形成水平降低。蛋白质表达和核糖核酸酶保护分析的进一步研究显示,GAF或ISGF3形成水平的降低可归因于Stat1蛋白表达的调节,Stat1是宿主防御机制中固有免疫的重要参与者。然而,这些调节作用并未干扰经IFN处理的细胞中下游效应基因IRF-1和561的激活。引入编码HCV结构蛋白和非结构蛋白的质粒DNA后,细胞的稳定转染子也表现出类似的效应。综上所述,这些结果表明,尽管单独的核心蛋白表达或与其他HCV蛋白共同表达会调节Jak/Stat信号通路的反式作用因子,但在IFN处理后,下游效应基因IRF-1和561的表达仍未受影响,这可能有助于宿主防御机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验